A review of decision support, risk communication and patient information tools for thrombolytic treatment in acute stroke: Lessons for tool developers

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Flynn, Darren ^a   Ford, Gary A ^a   Stobbart, Lynne ^a   Rodgers, Helen ^a   Murtagh, Madeleine J ^b   Thomson, Richard G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Acute stroke; Decision aids; Decision support; Patient information; Risk communication; Shared decision making; Thrombolysis

Indexed keywords

CEREBROVASCULAR ACCIDENT; DECISION SUPPORT SYSTEM; FIBRINOLYTIC THERAPY; HUMAN; INTERPERSONAL COMMUNICATION; PATIENT EDUCATION; PATIENT PARTICIPATION; REVIEW; RISK ASSESSMENT;

COMMUNICATION; DECISION SUPPORT SYSTEMS, CLINICAL; HUMANS; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; RISK ASSESSMENT; STROKE; THROMBOLYTIC THERAPY;

EID: 84879068186     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-225     Document Type: Review

References (82)

1. Shared decision making-the pinnacle of patient-centred care. Barry MJ, Edgman-Levitan S, New Engl J Med 2012 366 780 781 10.1056/NEJMp1109283 22375967
2. What do we mean by partnership in making decisions about treatment? Charles C, Whelan T, Gafni A, Brit Med J 1999 319 780 782 10.1136/bmj.319.7212. 780 10488014 (Pubitemid 29431540)
3. Policy support for patient-centered care: The need for measurable improvements in decision quality. Sepucha KR, Fowler FJ, Mulley AG, Health Aff (Millwood) 2004 Suppl Variation &22AR54 VAR62
4. Effect of clinical decision-support systems: a systematic review. Bright TJ, Wong A, Dhurjati R, Bristow E, Bastian L, Coeytaux RR, Samsa G, Hasselblad V, Williams JW, Musty MD, Wing L, Kendrick AS, Sanders GD, Lobach D, Ann Intern Med 2012 157 29 43 10.7326/0003-4819-157-1-201207030-00450 22751758
5. Decision aids for people facing health treatment or screening decisions. Stacey D, Bennett CL, Barry MJ, Col NF, Eden KB, Holmes-Rovner M, Llewellyn-Thomas H, Lyddiatt A, Légaré F, Thomson R, Cochrane Database Syst Rev 2011 Issue 10 rt. No.:CD001431 10.1002/14651858.CD001431.pub3
6. Coulter A, Ellins J, Swain D, Clarke A, Heron P, Rasul F, Magee H, Sheldon H, Assessing the quality of information to support people in making decisions about their health and healthcare Oxford: Picker Institute Europe 2006
7. General practice registrar responses to the use of different risk communication tools in simulated consultations: a focus group study. Edwards A, Elwyn G, Gwyn R, Brit Med J 1999 319 749 752 10.1136/bmj.319.7212.749 10488001 (Pubitemid 29431530)
8. Engaging patients in healthcare decisions in the emergency department through shared decision making: a systematic review. Flynn D, Pierce M, Hess E, Murad MH, Erwin PJ, Montori V, Thomson RG, Acad Emerg Med 2012 19 959 967 10.1111/j.1553-2712.2012.01414.x 22853804
9. F ramework for design and evaluation of complex interventions to improve health. Campbell M, Fitzpatrick R, Haines A, Kinmonth AL, Sandercock P, Spiegelhalter D, Tyrer P, Brit Med J 2000 321 694 696 10.1136/bmj.321.7262.694 10987780
10. How to develop web-based decision support interventions for patients: A process map. Elwyn G, Kreuwel I, Durand MA, Sivell S, Joseph-Williams N, Evans R, Edwards A, Patient Educ Couns 2011 82 260 265 10.1016/j.pec.2010.04.034 20627644
11. International Patient Decision Aids Standards (IPDAS) Collaboration: Developing a quality criteria framework for patient decision aids: online international Delphi consensus process. Elwyn G, O'Connor A, Stacey D, Volk R, Edwards A, Coulter A, Thomson R, Barratt A, Barry M, Bernstein S, Butow P, Clarke A, Entwistle V, Feldman-Stewart D, Holmes-Rovner M, Llewellyn-Thomas H, Moumjid N, Mulley A, Ruland C, Sepucha K, Sykes A, Whelan T, Brit Med J 2006 333 417 421 10.1136/bmj.38926.629329.AE 16908462 (Pubitemid 44320126)
12. Assessing the quality of decision support technologies using the international patient decision aid standards instrument (IPDASi). Elwyn G, O'Connor AM, Bennett C, Newcombe RG, Politi M, Durand MA, Drake E, Joseph-Williams N, Khangura S, Saarimaki A, Sivell S, Stiel M, Bernstein SJ, Col N, Coulter A, Eden K, Härter M, Rovner MH, Moumjid N, Stacey D, Thomson R, Whelan T, van der Weijden T, Edwards A, PLoS One 2009 4 4705 10.1371/journal.pone.0004705 19259269
13. International Patient Decision Aid Standards (IPDAS) Collaboration, 2012 Update of the IPDAS Collaboration Background Document http://ipdas.ohri.ca/ resources.html
14. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS and EPITHET trials. Lees KR, Bluhmki E, Kummer R, Brott TG, Toni D, Grotta JC, Albers GW, Kaste M, Marler JR, Hamilton SA, Tilley BC, Davis SM, Donnan GA, Hacke W, ECASS, ATLANTIS, NINDS and EPITHET rt-PA Study Group, Lancet 2010 375 1695 1703 10.1016/S0140-6736(10) 60491-6 20472172
15. ECASS Investigators: Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D, New Engl J Med 2008 359 1317 1329 10.1056/NEJMoa0804656 18815396
16. SITS-MOST investigators: Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Wahlgren N, Ahmed N, Dávalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G, Lancet 2007 369 275 282 10.1016/S0140-6736(07)60149-4 17258667 (Pubitemid 46138121)
17. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Lansberg MG, Albers GW, Wijman CA, Cerebrovasc Dis 2007 24 1 10 17971633 (Pubitemid 47026135)
18. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. The Third International Stroke Trial (IST-3) collaborative group, Lancet 2012 379 2352 2363 22632908
19. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G, Lancet 2012 379 2364 2372 10.1016/S0140-6736(12)60738-7 22632907
20. Consent to thrombolysis in acute ischaemic stroke: from trial to practice. Ciccone A, Lancet Neurol 2003 2 375 378 10.1016/S1474-4422(03)00412-5 12849154 (Pubitemid 38352565)
21. Informed consent for thrombolytic therapy for patients with acute ischemic stroke treated in routine clinical practice. Rosenbaum JR, Bravata DM, Concato J, Brass LM, Kim N, Fried TR, Stroke 2004 35 353 e355 10.1161/01.STR.0000136555.28503.55 15243145
22. Patient preferences for stroke outcomes. Solomon NA, Glick HA, Russo CJ, Lee J, Schulman KA, Stroke 1994 25 1721 1725 10.1161/01.STR.25.9.1721 8073449 (Pubitemid 24274961)
23. Situationally-sensitive knowledge translation and relational decision making in hyperacute stroke: a qualitative study. Murtagh MJ, Burges Watson DL, Jenkings KN, Lie MLS, Mackintosh JE, Ford GA, Thomson RG, PLoS One 2012 7 6 37066 10.1371/journal.pone.0037066 22675477
24. Intercollegiate Stroke Working Party, Stroke Improvement National Audit Programme (SINAP): Public Comprehensive Report 2012 http://www.rcplondon.ac.uk/ sites/default/files/sinap-comprehensive-public-report-2012.pdf
25. Response to symptoms of stroke in the UK: a systematic review. Lecouturier J, Murtagh MJ, Thomson RG, Ford GA, White M, Eccles M, Rodgers H, BMC Health Serv Res 2010 10 157 10.1186/1472-6963-10-157 20529351
26. National Audit Office, Progress in improving stroke care: a good practice guide London: National Audit Office 2010
27. A systematic review of barriers to delivery of thrombolysis for acute stroke. Kwan J, Hand P, Sandercock P, Age Ageing 2004 33 116 121 10.1093/ageing/afh064 14960425 (Pubitemid 38313108)
28. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke. Brown DL, Barsan WG, Lisabeth LD, Gallery ME, Morgenstern LB, Ann Emerg Med 2005 46 56 60 15988427 (Pubitemid 40916897)
29. Intravenous thrombolysis in acute ischaemic stroke: from trial exclusion criteria to clinical contraindications. An international Delphi study. Dirks M, Niessen LW, Koudstaal PJ, Franke CL, van Oostenbrugge RJ, Dippel DW, J Neurol Neurosurg Psychiatry 2007 78 685 689 17332052 (Pubitemid 46998835)
30. Thrombolysis for acute ischaemic stroke. Wardlaw JM, Murray V, Berge E, del Zoppo GJ, Cochrane Database Syst Rev 2009 4 CD000213
31. Modification of Rankin Scale: Recovery of motor function after stroke. Bonita R, Beaglehole R, Stroke 1988 19 1497 1500 10.1161/01.STR.19.12.1497 3201508 (Pubitemid 19005804)
32. Gunning R, The technique of clear writing New York, NY: McGraw-Hill 1952
33. Bond S, Gunning Fog Index http://gunning-fog-index.com/index.html
34. Developing and testing a patient information booklet for thrombolysis used in acute stroke. Knapp P, Wanklyn P, Raynor DK, Waxman R, Int J Pharm Pract 2010 18 362 369 10.1111/j.2042-7174.2010.00060.x 21054597
35. American Academy of Neurology, American College of Emergency Physicians, and American Heart Association/American Stroke Association: Tissue plasminogen activator (tPA): what you should know http://www.heart.org/idc/groups/ahaecc- public/@wcm/@hcm/@gwtg/documents/downloadable/ucm-431151.pdf
36. Patient UK, Thrombolytic treatment of acute ischaemic stroke [the version of this tool that was critically analysed in this paper is no longer available via the web§ssup§a§esup§]
37. Stockport NHS Foundation Trust, Stroke thrombolysis (clot dissolving drugs): an information leaflet [the version of this tool that was critically analysed in this paper is no longer available via the web§ssup§a§ esup§]
38. University Hospitals Bristol NHS Foundation Trust, Acute stroke thrombolysis [the version of this tool that was critically analysed in this paper is no longer available via the web§ssup§a§esup§]
39. Genentech, After a stroke starts: what you need to know about clot-busting therapy http://www.icahn.org/files/Stroke-Library-/Tools/activase- patientbroch.pdf
40. Thunder Bay Regional Health Sciences Centre, Information about tPA http://www.tbrhsc.net/clinical-partners/regional
41. Chest, Heart and Stroke Scotland, Thrombolysis treatment after stroke [the version of this tool that was critically analysed in this paper is no longer available via the web§ssup§a§esup§]
42. Ottawa Hospital, Information for patients and families about tPA (Tissue Plasminogen) for stroke http://www.ottawaneurology.ca/docs/Stroke-Pack/ stroke0015.pdf
43. Massachusetts General Hospital Stroke Service: Patient information sheet http://www2.massgeneral.org/stopstroke/pdfs/ Patient%20Information%20Sheet%20(IV%20tPA%20in%20the%203-4.5hrs).pdf
44. South Tyneside NHS Foundation Trust: Stroke thrombolysis-information sheet http://www.easyhealth.org.uk/sites/default/files/ Stroke%20Thrombolysis%20%E2%80%93%20Information%20Sheet.pdf
45. Gloucestershire Hospitals NHS Foundation Trust, Stroke thrombolysis information for patients and relatives http://www.strokeunitglos.nhs.uk/ strokeunitgl282427.html
46. NHS Wales, Patient and carer information leaflet: thrombolysis in stroke [the version of this tool that was critically analysed in this paper is no longer available via the web§ssup§a§esup§]
47. Saint Alphonsus Health System Outreach Program, t-PA information sheet http://www.saintalphonsus.org/documents/StrokeThrombolyticsConsentForm.pdf
48. NHS Fife, Patient information sheet for thrombolysis http://www.sctt. scot.nhs.uk/wp-content/uploads/2012/11/FifeThrombolysisprotocolJan10v1.pdf
49. Royal United Hospital Bath NHS Trust, Information for patients about thrombolysis (clot dissolving drugs) for stroke [the version of this tool that was critically analysed in this paper is no longer available via the web§ssup§a§esup§]
50. University of North Staffordshire NHS Trust, Thrombolysis (treatment with a clot dissolving drug-alteplase) for acute stroke http://www.stroke-in-stoke. info/acutestrokefiles/thrombolysispathway.doc
51. American Academy of Emergency Medicine, tPA for stroke-potential benefit, risk and alternatives http://www.aaem.org/UserFiles/file/tpaedtool-AAEM.pdf 23850642
52. Assessment and improvement of figures to visually convey benefit and risk of stroke thrombolysis. Gadhia J, Starkman S, Ovbiagele B, Ali L, Liebeskind D, Saver JL, Stroke 2010 41 300 306 10.1161/STROKEAHA.109.566935 20056928
53. Genentech, Hypothetical representation of 16 patients treated with Activase (t-PA) vs 16 patients treated with placebo is based on NINDS results at 3 months [the version of this tool that was critically analysed in this paper is no longer available via the web§ssup§a§esup§]
54. NHS Lothian, Clot-busting treatment for acute stroke: patient information [ http://www.lothianstrokemcn.scot.nhs.uk/network-groups/documents/ ThrombolysisPatientInfo-WW.pdf ]
55. NHS Lothian, Clot-busting treatment for acute stroke: patient information http://www.strokeadvancingmodules.org/resources/ThrombolysisPatientInfo.pdf
56. HandiStroke: a handheld tool for the emergent evaluation of acute stroke patients. Shapiro J, Bessette M, Levine SR, Baumlin K, Acad Emerg Med 2003 10 1325 1328 10.1111/j.1553-2712.2003.tb00005.x 14644783 (Pubitemid 37531853)
57. The Stroke-Thrombolytic Predictive Instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W, Stroke 2006 37 2957 2962 10.1161/01.STR. 0000249054.96644.c6 17068305 (Pubitemid 44900816)
58. The outcome wheel: a potential tool for shared decision-making in ischemic stroke thrombolysis. Cunningham VL, CJEM 2008 10 545 551 19000351
59. Stroke Northumbria, Stroke Thrombolysis Pathway 2009: Information to give to patients/relatives before administration of Alteplase [the version of this tool that was critically analysed in this paper is no longer available via the web§ssup§a§esup§]
60. Risk communication in the clinical consultation. Thomson R, Edwards A, Grey J, Clin Med 2005 5 465 469 10.7861/clinmedicine.5-5-465 16268328 (Pubitemid 41503098)
61. Why do single event probabilities confuse patients? Statements of frequency are better for communicating risk. Gigerenzer G, Galesic M, Brit Med J 2012 344 245 10.1136/bmj.e245 22236599
62. External validity of randomised controlled trials: "To whom do the results of this trial apply?" Rothwell PM, Lancet 2005 365 82 93 10.1016/S0140-6736(04)17670-8 15639683 (Pubitemid 40082150)
63. Graphical perception and graphical methods for analyzing scientific data. Cleveland WS, McGill R, Science 1985 229 828 833 10.1126/science.229.4716.828 17777913
64. Doak CC, Doak LG, Root JH, Teaching patients with low literacy skills Philadelphia, PA: Lippincott-Raven 1996
65. Communicating with patients who cannot read. Weiss BD, Coyne C, New Engl J Med 1997 337 272 274 10.1056/NEJM199707243370411 9227936 (Pubitemid 27310446)
66. Coulter A, Entwistle V, Gilbert D, Informing patients: an assessment of the quality of patient information materials London: King's Fund 1998
67. Measuring quality of patient information documents with an expanded EQIP scale. Charvet-Berard AI, Chopard P, Perneger TV, Patient Educ Couns 2008 70 407 411 10.1016/j.pec.2007.11.018 18242935
68. A review of decision support technologies for amniocentesis. Durand MA, Boivin J, Elwyn G, Hum Reprod Update 2008 14 659 668 10.1093/humupd/dmn037 18772266
69. Where is the theory?: Evaluating the theoretical frameworks described in decision support technologies. Durand MA, Stiel M, Boivin J, Elwyn G, Patient Educ Couns 2008 71 125 135 10.1016/j.pec.2007.12.004 18242040
70. Assessment of the quality of existing patient educational tools focused on sudden cardiac arrest: a systematic evaluation by the Sudden Cardiac Arrest Thought Leadership Alliance. Hazelton G, Al-Khatib SM, Fonarow GC, Thomas KL, Hayes D, Sanders GD, Campbell SM, Yancy C, Peterson ED, Sears S, Patient Prefer Adherence 2013 7 361 368 23641150
71. DARTS Team: Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation. Thomson R, Robinson A, Greenaway J, Lowe P, Qual Saf Health Care 2002 11 25 31 10.1136/qhc.11.1.25 12078365 (Pubitemid 35265298)
72. The chest pain choice decision aid: A randomized trial. Hess EP, Knoedler MA, Shah ND, Kline JA, Breslin M, Branda ME, Pencille LJ, Asplin BR, Nestler DM, Sadosty AT, Stiell IG, Ting HH, Montori VM, Circ Cardiovasc Qual Outcomes 2012 5 251 259 10.1161/CIRCOUTCOMES.111.964791 22496116
73. Theory-based design and field-testing of an intervention to support women choosing surgery for breast cancer: BresDex. Sivell S, Marsh W, Edwards A, Manstead AS, Clements A, Elwyn G, Patient Educ Couns 2012 86 179 188 10.1016/j.pec.2011.04.014 21571485
74. Gigerenzer G, Reckoning with risk London: Penguin 2002
75. Using alternative statistical formats for presenting risks and risk reductions. Akl EA, Oxman AD, Herrin J, Vist GE, Terrenato I, Sperati F, Costiniuk C, Blank D, Schünemann H, Cochrane Database Syst Rev 2011 Issue 3 rt. No.: CD006776 10.1002/14651858.CD006776.pub2
76. Visualizing uncertainty about the future. Spiegelhalter D, Pearson M, Short I, Science 2011 333 1393 1400 10.1126/science.1191181 21903802
77. The impact of the format of graphical presentation on health-related knowledge and treatment choices. Hawley ST, Zikmund-Fisher BJ, Ubel PA, Jancovic A, Lucas T, Fagerlin A, Patient Educ Couns 2008 73 448 455 10.1016/j.pec.2008. 07.023 18755566
78. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Philips Z, Ginnelly L, Sculphe M, Claxton K, Golder S, Riemsma R, Woolacott N, Glanville J, Health Technol Assess 2004 8 umber 36 http://www.hta.ac.uk/execsumm/summ836.htm
79. Cultural influences on the physician-patient encounter: the case of shared treatment decision-making. Charles C, Gafni A, Whelan T, O'Brien MA, Patient Educ Couns 2006 63 262 267 10.1016/j.pec.2006.06.018 17000073 (Pubitemid 44540194)
80. The framing of decisions and the psychology of choice. Tversky A, Kahneman D, Science 1981 211 453 458 10.1126/science.7455683 7455683 (Pubitemid 11145313)
81. Implementing shared decision making in the NHS. Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R, Brit Med J 2010 341 971 973
82. Shared decision making: a model for clinical practice. Elwyn G, Frosch D, Thomson R, Joseph-Williams N, Lloyd A, Kinnersley P, Cording E, Tomson D, Dodd C, Rollnick S, Edwards S, Barry M, J Gen Int Med 2012 27 1361 1367 10.1007/s11606-012-2077-6